NCT04580511View on ClinicalTrials.gov

Safety and Clinical Performance of a Biological Matrix Used in Abdominal Wall Reconstruction

Active, not recruitingOBSERVATIONAL
Enrollment

92

Participants

Timeline

Start Date

November 4, 2020

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions
Abdominal Wall DefectAbdominal Wall InjuryAbdominal Hernia
Interventions
DEVICE

CELLIS (Porcine Acellular Dermal Matrix, PADM)

Biological membrane used in abdominal reconstruction

Trial Locations (4)

44093

CHU Nantes Hôtel Dieu, Nantes

Unknown

CHU Caen Normandie, Service de Chirurgie Digestive, Caen

Groupe Hospitalier La Rochelle - Ré - Aunis, La Rochelle

CHU Montpellier, Hôpital Saint-Eloi, Pôle digestif, Service de Chirurgie Digestive B et Transplantation, Montpellier

Sponsors

Lead Sponsor

Meccellis Biotech
All Listed Sponsors
lead

Meccellis Biotech

INDUSTRY

NCT04580511 - Safety and Clinical Performance of a Biological Matrix Used in Abdominal Wall Reconstruction | Biotech Hunter | Biotech Hunter